Di seguito i lavori presentati da GOIRC all'Asco 2023,
Prognostic role of HER2 expression in patients with ER-positive/HER2-negative breast cancer: Results from a population-based cancer registry study. ABS#547, POSTER#377
Antonino Musolino, Olga Serra, Benedetta Pellegrino, Chiara Tommasi, Daniele Zanoni, Laura Cortesi, Fabio Canino, Federico Piacentini, Paolo Sgargi, Maria Michiara
Use of direct oral anticoagulants (DOACs) in oncology: A phase IV study on impact of edoxaban treatment in Italian patients with cancer with venous thromboembolism during antineoplastic therapy (EDOI trial, GOIRC 05-2018) ABS#6564, POSTER#56
Filippo Giovanardi, Massimo Di Maio, Erika Gervasi, Alessandra Romagnani, Angela Damato, Marcello Tiseo, Stefano Tamberi, Vincenzo Montesarchio, Salvatore Grisanti, Marco Platania, Annamaria Catino, Rodolfo Passalacqua, Andrea Vincent Bonetti, Giovanni Vicario, Silvia Finotto, Fabio Gelsomino, Carmine Pinto